Page last updated: 2024-11-09

2-(1h-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate: activator for peptide synthesis [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID51341376
SCHEMBL ID2598627
SCHEMBL ID20996136
MeSH IDM0201641

Synonyms (18)

Synonym
x5i03tzq8d ,
2-hbtu
unii-x5i03tzq8d
methanaminium, n-((1h-benzotriazol-1-yloxy)(dimethylamino)methylene)-n-methyl-, hexafluorophosphate(1-)
2-(1h-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate
1-[bis(dimethylamino)methylene)-1h-benzotriazolium 3-oxide hexafluorophosphate
bis(dimethylamino)(3-oxido-1h-benzotriazol-1-yl)methylium hexafluorophosphate
1-[bis(dimethylamino)methylene]-1h-benzotriazolium 3-oxide hexafluorophosphate
1-[bis(dimethylamino)methylene]-1h-benzotriazolium-3-oxide hexafluorophosphate
BSKUEERROYGAFF-UHFFFAOYSA-N
hbtu [mi]
1h-benzotriazolium, 1-(bis(dimethylamino)methylene)-, hexafluorophosphate(1-), 3-oxide
n-hbtu
SCHEMBL2598627
SCHEMBL20996136
AKOS030214175
1-((dimethylamino)(dimethyliminio)methyl)-1h-benzo[d][1,2,3]triazole 3-oxide hexafluorophosphate
1-(bis(dimethylamino)methylene)-1h-benzo[d][1,2,3]triazole-1-ium 3-oxide hexafluorophosphate(v)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (18.18)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies5 (41.67%)4.05%
Observational0 (0.00%)0.25%
Other7 (58.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]